Methods to evaluate transporter activity in cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-60761-700-6_5PMID 20419431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Detection Using a PET Tracer, 11C-Glycylsarcosine, Targeted to H+/Peptide Transporter

  2008cited by this paper
• Drug transporters as targets for cancer chemotherapy.

  2007cited by this paper
• Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

  2006cited by this paper
• Up-regulation of the amino acid transporter ATB(0,+) (SLC6A14) in carcinoma of the cervix.

  2006cited by this paper
• L‐type amino acid transporter 1 as a potential molecular target in human astrocytic tumors

  2006cited by this paper
• Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.

  2006cited by this paper
• OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib.

  2006cited by this paper
• Organic cation transporters are determinants of oxaliplatin cytotoxicity.

  2006cited by this paper
• The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

  2006cited by this paper
• Characterization of the organic cation transporter SLC22A16: a doxorubicin importer.

  2005cited by this paper
• Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans.

  2005cited by this paper
• [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice.

  2005cited by this paper
• Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

  2005cited by this paper
• Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.

  2004cited by this paper
• Expression of the nucleoside‐derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors

  2004cited by this paper
• The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma

  2004cited by this paper
• Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis.

  2003cited by this paper
• Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

  2003cited by this paper
• P-glycoprotein: from genomics to mechanism

  2003cited by this paper
• Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.

  2002cited by this paper
• Transport of D-serine via the amino acid transporter ATB(0,+) expressed in the colon.

  2002cited by this paper
• Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells.

  2002cited by this paper
• Na+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+).

  2001cited by this paper
• Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.

  2001cited by this paper
• Rapid Report

  2001cited by this paper
• Cancer cell‐targeted drug delivery utilizing oligopeptide transport activity

  2000cited by this paper
• Novel mechanisms of drug resistance in leukemia

  2000cited by this paper
• An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2.

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)*

  1998cited by this paper
• Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.

  1997cited by this paper
• Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products.

  1996cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper

• In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity

  2022cites this paper
• A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.

  2017cites this paper
• A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer

  2017cites this paper
• Major constituents of Cistanche tubulosa, echinacoside and acteoside, inhibit sodium-dependent glucose cotransporter 1-mediated glucose uptake by intestinal epithelial cells

  2017cites this paper
• Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3.

  2016cites this paper
• Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis

  2015cites this paper
• Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.

  2015cites this paper
• Identification of microRNAs as a class of biomarkers for the early diagnosis of prostate cancer : an in silico and molecular approach

  2015cites this paper
• OATP2A1/SLCO2A1-mediated prostaglandin E2 loading into intracellular acidic compartments of macrophages contributes to exocytotic secretion.

  2015cites this paper
• Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

  2013cites this paper